Healio
›
Infectious Disease
›
Highlights from HIV11 Congress
Welcome to the Highlights from HIV11 Congress resource page. This is your central portal for information presented at the Eleventh International Congress on Drug Therapy in HIV Infection, including novel treatment options, breaking clinical trials and guideline updates. In addition to breaking news, this resource page features onsite video interviews with leading experts to get their reactions on some of the clinical updates and news presented at the conference, and what implications they have for the future.
Video Coverage
Exhaustion of HIV therapies expected for some patients
GLASGOW — As treatment options are exhausted in the coming years, a substantial difference in life expectancy between people living with HIV and the general population is expected —particularly for those with HIV acquired at a younger age or for those who are highly treatment-experienced, according to presenter James Jansson, research assistant in the surveillance and evaluation program of public health at The Kirby Institute in Australia.
A model aimed at projecting the future life expectancy of people living with HIV in resource-rich settings estimated that the median time until exhaustion of currently available treatment options is 43.4 years and that 10% will use up all currently available ART options after only 22.6 years. More »
News Coverage from HIV11 Congress
-
- November 15, 2012
- GLASGOW — A new combination tablet including rilpivirine, emtricitabine and tenofovir was non-inferior to the existing combination tablet including efavirenz, emtricitabine and tenofovir, according to results from the STaR study presented here at the HIV11 Congress. More »
-
- November 15, 2012
- GLASGOW — The risk for Kaposi’s sarcoma, non-Hodgkin’s lymphoma and cervix uteri cancer in HIV-1-positive patients decreased from 1992 to 2009, according to results from FHDH-ANRS CO4. More »
-
- November 15, 2012
- GLASGOW — Approximately 16% of men who have sex with men included in the Antiretrovirals, Sexual Transmission Risk and Attitudes study reported having recent unprotected sex with an HIV-discordant partner, according to findings presented here. More »
-
- November 14, 2012
- GLASGOW — Treatment incidence for acute hepatitis C virus among coinfected patients increased from 1998 to 2007 and appears to be more frequent in patients with higher CD4 counts and lower HIV-RNA, which is in line with current guidelines, according to data presented here. More »
-
- November 13, 2012
- GLASGOW — Six-year follow-up data on the Children with HIV Early Antiretroviral Therapy trial presented here suggest that a significant virologic response was obtained in infants assigned to ART at an early age — treatment interruption did not adversely affect virological outcomes. More »
-
- November 13, 2012
- GLASGOW — Researchers reported an increase in vaginal delivery rates across Europe, from 17% to 52%, after most national guidelines were updated between 2001 and 2009 to recommend vaginal deliveries for HIV-positive women with undetectable or very low viral load. More »
-
- November 13, 2012
- GLASGOW — Analysis of patients from the large EuroSIDA cohort revealed a significant increase in the incidence of acute hepatitis C virus from 2002 to 2010. More »
-
- November 13, 2012
- GLASGOW — Global HIV drug-resistance surveillance data — initiated by WHO in 2004 after a 26-fold increase in ART use in low- and middle-income countries — indicate an overall increase in HIV drug resistance, particularly with non-nucleoside reverse transcriptase inhibitors
in Africa. More »
-
- November 13, 2012
- GLASGOW — Despite major advances in HIV therapy, the number of new HIV infections in Europe remains high, and new prevention strategies must be assessed to curb the incidence of HIV infection, Jean-Michel Molina, MD, of Saint-Louis Hospital and University of Paris, said here at the HIV11 Congress. More »
-
- November 13, 2012
- GLASGOW — Researchers here reported an increased incidence of late gadolinium enhancement detected on cardiac magnetic resonance imaging in asymptomatic HIV-positive patients. More »
-
- November 13, 2012
- GLASGOW — The pros and cons of when to initiate ART in asymptomatic patients with HIV were debated here at the HIV11 Congress. More »
-
- November 12, 2012
- GLASGOW — HIV-positive patients on a suppressive ART regimen have high levels of total cholesterol, HDL cholesterol and triglycerides, according to new findings from the Data Collection on Adverse Events of Anti-HIV Drugs, or D:A:D, study. More »
-
- November 12, 2012
- GLASGOW — New data presented today at the HIV11 Congress suggest the need for new efforts to re-engage patients with HIV in critical care in Europe. More »
-
- November 9, 2012
- The Infectious Disease News editorial staff has already landed in Glasgow, Scotland, in preparation for one of the year’s biggest events in infectious disease — the Eleventh International Congress on Drug Therapy in HIV Infection. More »